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Aim: The expression of cysteine cathepsins in human carious dentine suggests that this
enzyme contributes to the collagen degradation in caries progress. This study investigated
whether silver diamine fluoride (SDF) inhibited the activity of cysteine cathepsins.
Methods: Three commercial SDF solutions with concentrations at 38%, 30% and 12% were
studied. Two fluoride solutions with the same fluoride ion (F) concentrations as the 38%
and 12% SDF solutions, and 2 silver solutions with the same silver ion (Ag+) concentrations
as the 38% and 12% SDF solutions were prepared. Five samples of each experimental
solution were used to study their inhibitory effect on two cathepsins (B and K) using
cathepsin assay kits. Positive control contained assay buffer and cathepsins dilution was
used to calculate the percentage inhibition (difference between the mean readings of the
test solution and control solution divided by that of the control group).
Results: The percentage inhibition of 38%, 30% and 12% SDF on cathepsin B were 92.0%,
91.5% and 90.3%, respectively ( p < 0.001); on cathepsin K were 80.6%, 78.5% and 77.9%,
respectively ( p < 0.001). Ag+ exhibited the inhibitory effect against both cathepsin B and K
with or without the presence of F ( p < 0.01). The solutions containing Ag+ have significantly
higher inhibitory effect than the solutions containing F only ( p < 0.01).
Conclusion: According to this study, SDF solution at all 3 tested concentrations significantly
inhibited the activity of cathepsin B and K.
# 2013 The Authors. Published by Elsevier Ltd. 
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A recent review concluded that silver diamine fluoride (SDF) is
a safe, effective, efficient, and equitable caries-preventive
agent that appears to meet the criteria of the WHO Millennium
Goals and the US Institute.1 Clinical trials showed that SDF
prevented and arrested coronal caries in primary teeth2,3 and* Corresponding author at: Faculty of Dentistry, The University of Hong 
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Open access undroot caries in permanent teeth. Numerous laboratory studies
have found that SDF is effective in increasing microhardness5–
7 and the mineral content of dentine caries.6,8,9 Apart from the
demineralisation of hydroxyapatite, caries progression also
involves significant degradation of dentine collagen.10 Mam-
malian collagenolytic enzymes such as matrix metalloprotei-
nases (MMPs) were found to play a crucial role in collagen
degradation.11 In addition, cysteine cathepsins (or cathepsins)Kong, 34, Hospital Road, Hong Kong Special Administrative Region.
er CC BY-NC-ND license. 
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components.12,13 Tersariol et al.,12 reported that cathepsin
activities were associated with MMPs activities in dentine.
Scaffa et al.,14 suggested that cathepsins may also be
responsible for the collagen degradation in caries lesions.
Hence, the inhibition of MMPs and cathepsins may contribute
to caries arrest.
Cathepsins are proteolytic enzymes that can be identified
in dentine caries and human pulp. They are members of the C1
family of papain-like enzymes, which are the largest and the
best-characterised family of cysteine peptidases. Cathepsins
can extracellularly degrade type I collagen and proteoglycans,
which are the main components of the dentine organic
structure. Cathepsins are active and stable in acidic environ-
ments and mostly unstable at neutral acidity.15 The autocata-
lytic activation of cathepsins is substantially accelerated in the
presence of anionic polysaccharides.16
Cathepsins are differentiated by their structure, catalytic
mechanism, and the proteins they cleave. Cathepsin B can be
found in human carious dentine and saliva. Its activity varies
in relation to the depth and age of carious lesions, while
remaining stable in saliva.13 Cathepsin B cleaves in the non-
helical telopeptide extensions of collagens.17 Cathepsin K can
catabolize collagen and break down dentine. It cleaves the
collagen at the triple helical region.15 These properties suggest
that cathepsins may play crucial roles in collagen breakdown
in dentine caries lesions.
We found that SDF strongly inhibited the proteolytic
activity of MMP-2, MMP-8, and MMP-9, which are three of
the main MMPs that take part in collagen degradation,18 our
resent study also demonstrated that SDF prevented dentine
collagen degradation from bacterial collagenase challenge.19
To serve as an effective caries arresting agent, SDF needs to
function as a broad-spectrum inhibitor that restrains other
dentinal proteolytic enzymes. Unlike the MMPs first discov-
ered in dentine pathologies over 15 years ago, cathepsins were
recently detected in dentine.12,13,15 However, no studies have
examined the effectiveness of SDF on cathepsins. Thus, the
aim of this study was to investigate the inhibitory effects of 3
common, commercially available SDF solutions at different
concentrations on cysteine cathepsins. Freshly prepared silver
nitrate (AgNO3) and sodium fluoride (NaF) solutions were used
for comparison. Two null hypotheses are tested: firstly, there
is no difference in inhibitory effect on cysteine cathepsins by
SDF, AgNO3 and NaF solutions; and secondly, there is noTable 1 – Fluoride and silver content and acidity (pH) of the 10
Group Product Chemicals 
1 Saforide 38% Ag(NH3)2F 
2 Buffered saforide Ag(NH3)2F + HN
3 Cariestop 30% Ag(NH3)2F 
4 Buffered cariestop 30% Ag(NH3)2F + HN
5 Cariestop 12% Ag(NH3)2F 
6 Buffered cariestop 12% Ag(NH3)2F + HN
7 Silver solution A AgNO3
8 Silver solution B AgNO3
9 Fluoride solution A NaF + KFa
10 Fluoride solution B NaF 
a Potassium fluoride was added to 4% NaF to form a solution with 44,80difference in inhibitory effect on cysteine cathepsins by 38%,
30%, and 12% SDF solutions.
2. Methods and materials
2.1. Reagents
Commercially available SDF solutions at concentrations of
12% (Cariostop, Biodinamica, Brazil), 30% (Cariostop, Biodina-
mica, Brazil), and 38% (Saforide, Toyo Seiyaku Kasei, Japan)
were selected for this in vitro study. Freshly silver and fluoride
solutions were prepared, which contained equivalent con-
centrations of silver ions (Ag+) and fluoride ions (F) as the 38%
and 12% solutions of SDF, respectively. The 3 commercially
available SDF solutions had high pH values (pH = 12–13), which
could have affected the cysteine cathepsin activity. Therefore,
3 control groups of SDF at 38%, 30%, and 12% buffered with 10%
nitric acid (HNO3) to lower the acidity (pH = 9) were prepared.
Five samples of each experimental solution were used in this
study. The 10 experimental solutions assessed were num-
bered groups 1–10, as shown in Table 1.
2.2. Inhibition of cathepsin enzymatic activity by the
experimental solutions
We used human recombinant cathepsins and Sensolyte
cathepsin assay kits (cathepsins B and K) from AnaSpec Inc.
(San Jose, CA, USA). The Sensolyte cathepsin assay kit is a
homogeneous assay that can be used to detect enzyme activity
and for screening cathepsin inhibitors. The cathepsin B
enzyme was diluted 1000-fold in a dithiothreitol (DTT)-
containing assay buffer, while the cathepsin K enzyme was
pro-incubated with an equivalent amount of activation buffer
for 40 min at room temperature before being diluted 300-fold
in a DTT-containing assay buffer. The enzyme diluents were
prepared immediately before use according to the protocol
suggested by the manufacturer. Then, 40 ml diluted cathepsin
enzyme and 10 ml experimental solution were added to each
well of a black fluorometric 96-well microtiter plate (Fisher
Scientific, Gainesville, FL, USA). The wells of the microtiter
plate also received 50 ml of diluted cathepsin substrate
solution (dilution factor: 1:100) to give a total volume in each
well of 100 ml. Thus, the concentration of the experimental
solution was diluted 10 times during the reaction. Namely, the experimental solutions.
F (ppm) Ag+ (ppm) pH
44,800 255,000 13
O3 44,800 255,000 9
35,400 200,000 12
O3 35,400 200,000 9
14,150 80,000 12
O3 14,150 80,000 9
– 255,000 10
– 80,000 10
44,800 – 9
14,150 – 9
0 ppm fluoride ions.
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solution. A positive control containing recombinant cathe-
psins (with no potential anti-cathepsin agent) was used as a
reference to calculate the percentage of inhibition. A substrate
control containing assay buffer only was used to check the
background fluorescence of the substrate. Another test control
containing experimental solutions, without recombinant
cathepsins, was used to measure the auto fluorescence of
the experimental solutions. The assay buffer and cathepsin
substrate were added to the control wells to obtain the 100 ml
total volume.20
2.3. Fluorescence reference standard
Fluorescence resonance energy transfer (FRET) solutions at
serial concentrations were prepared as suggested by the
manufacturer and used as the fluorescence reference stan-
dard. Serial dilutions of 1:2 were performed to obtain FRET
solutions at concentrations of 2.5, 1.25, 0.625, 0.3125, 0.156,
0.078, and 0 mM. Fifty ml of each diluted HiLteFluorTM 488
fluorescence reference solution was added to each well. The
cathepsin substrates were then added to the wells to form
100 ml solutions for evaluation. This reference standard is used
as an indicator of the amount of final product from the
enzymatic reaction.
2.4. End-point reading
The reagents were mixed gently in the dark for 10 s. The
fluorescence intensity of the assay was measured at excita-
tion/emission (490 nm/520 nm) using http://www.perkinel-
mer.com/Catalog/Family/ID/VICTOR X Multilabel Plate
Reader a multitask plate reader (1420 Victor PerkinElmer,
Boston, USA) with an associated computer program (Wallac
1420 manager PerkinElmer, Boston, USA) at room tempera-
ture. The data (end-point readings of cathepsin activity) wereTable 2 – Mean end-point values (cysteine cathepsins activity
Group (n = 5 each) En
Cathe
1. 38% SDF (pH 13) 0.053 
2. 38% SDF (pH 9) 0.054 
3. 30% SDF (pH 12) 0.056 
4. 30% SDF (pH 9) 0.055 
5. 12% SDF (pH 12) 0.064 
6. 12% SDF (pH 9) 0.062 
7. Silver solution A 0.054 
8. Silver solution B 0.064 
9. Fluoride solution A 0.45 (0
10. Fluoride solution B 0.50 (0
11. Positive control 0.66 (0
p value <0.001
LSD comparison a < b <
Comparing the effect of the pH of SDF solutions at different concentrations
38%—Group 1 vs. 2 p = 0.3
30%—Group 3 vs. 4 p = 0.2
12%—Group 5 vs. 6 p = 0.2
Different letters indicate a statistically significant difference between thobtained after 1 h and expressed as relative fluorescence units
(RFU). The RFUs were subsequently converted to mM (mg/ml)
based on standard curves (R2 > 0.99) generated with the HiLte
FluorTM 488 fluorescence standard. A low concentration value
reflected a high inhibitory effect on cathepsins. The percent-
age inhibition was calculated from the difference between the
mean values of the test group and the reference (positive
control) group, divided by that of the reference group.18
2.5. Statistical analysis
All data were assessed for normal distribution using the
Shapiro–Wilk test for normality. One-way ANOVA with LSD
multiple comparison tests were used to detect differences
between the cathepsin concentration values (mg/ml) among all
the experimental groups. Two-way ANOVA with simple main
effect was used to compare the inhibitory effects of different
concentrations of Ag+ and F (as two independent variables)
on cathepsins B and K. Analyses were performed with the
computer software SPSS Statistics – V20.0 (IBM Corporation,
Armonk, USA). The level of statistical significance for all tests
was set at 0.05.
3. Results
The mean end-point values of the 10 experimental groups and
the positive control are shown in Table 2. No significant
difference in end-point values was detected among all the
groups containing Ag+ (including all the SDF groups and 2
silver solution groups, Groups 1–8) for cathepsin B, while the
values in Group 1–8 were lower than positive control (Group
11) and two fluoride solution groups (Groups 9 and 10); no
significant difference in end-point values was detected among
all the SDF groups (Groups 1–6) for cathepsin K, while the
values in Group 1–6 were lower than positive control (Group) of the experimental solutions.
d-point values (cathepsin activity) in mg/ml mean (SD)
psin-B Cathepsin-K
(0.002)a 0.19 (0.005)a
(0.002)a 0.20 (0.010)a
(0.001)a 0.21 (0.007)a
(0.001)a 0.21 (0.011)a
(0.002)a 0.21 (0.008)a
(0.002)a 0.23 (0.020)a
(0.002)a 0.30 (0.012)b
(0.003)a 0.33 (0.013)b
.012)b 0.69 (0.046)c
.025)c 0.80 (0.117)d
.017)d 0.96 (0.047)e
 <0.001
 c < d a < b < c < d < e
6 p = 0.08
2 p = 0.21
8 p = 0.18
e groups ( p < 0.05).
Fig. 1 – Two-way ANOVA with simple main effect analysis. (A) The simple main effect of high-concentration Ag+
(255,000 ppm) and FS (44,800 ppm) on the cathepsin B inhibitory effect. Stars in the middle of the lines indicate that Ag+ has
a significant inhibitory effect no matter if FS is present (solid line) or not (round dot line). Star in the middle of two right
points indicates that FS has a significant inhibitory effect in the absence of Ag+. Triangle in the left side indicates that FS
does not have a significant inhibitory effect in the presence of Ag+. (B) The simple main effect of low-concentration Ag+
(80,000 ppm) and FS (14,150 ppm) on the cathepsin B inhibitory effect. Similar patterns are observed in Fig. 1A. (C) The
simple main effect of high-concentration Ag+ (255,000 ppm) and FS (44,800 ppm) on the cathepsin K inhibitory effect. Stars
in the middle of the lines indicate that Ag+ has a significant inhibitory effect no matter if FS is present (solid line) or not
(round dot line). Stars in the middle of two points indicate that FS has a significant inhibitory effect no matter if Ag+ is
present (left points) or not (right points). (D) The simple main effect of low-concentration Ag+ (80,000 ppm) and FS
(14,150 ppm) on the cathepsin K inhibitory effect. Similar patterns are observed in Fig. 1C.
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solution groups (Group 7 and 8). No significant differences in
end-point values were detected between the commercial SDF
products (pH value at 12–13) and the corresponding buffered
groups at pH 9 at 38%, 30%, and 12%.
The inhibitory effects of 12% and 38% SDF solutions against
cathepsin B and K were summarised in Fig. 1. SDF and Ag+
solution had similar inhibition against cathepsin B activity,
suggesting cathepsin B activity could be inhibited by Ag+. F
solution also inhibited cathepsin B activity, but its inhibition
effect is less than SDF and Ag+ solution. In addition, SDF, Ag+
solution and F solution inhibited cathepsin K activity; and
SDF had a higher inhibition effect on cathepsin K activity than
Ag+ solution and F solution.
The percentage inhibitions of the experimental solutions of
the two cathepsins are shown in Fig. 2. The percentage
inhibitions of 38% SDF for cathepsins B and K were 92.0% and
80.6%, respectively. The percentage inhibitions of 30% SDFand 12% SDF for cathepsins B and K were also higher than 70%,
and no statistically significant difference from percentage
inhibitions of 38% SDF. Although F also had statistically lower
end-point values than the positive control, the percentage
inhibitions were only around 30% in high concentration
(F Solution A) and 20% in low concentration (F Solution B).
The inhibitory effect of F on cathepsins B and K, although
statistically significant, is weak (20–30%).
4. Discussion
Clinical trials have demonstrated that SDF can arrest
caries.2,3,21 However, the mechanism of action is not yet fully
known. Previous studies on the mechanisms of SDF have
mostly focused on antimicrobial effects and mineral changes
in tooth structure.5–8 Caries destruction in dentine is different
from that in enamel because dentine contains about 30% by
Fig. 2 – Percentage inhibition of (A) cathepsin B and (B) cathepsin K of the experimental groups.
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the dentine matrix or in saliva play a significant role in dentine
collagen degradation.22 Recent studies have discovered that
cathepsins are another crucial enzyme that may activate
MMPs and also be directly involved in collagen degrada-
tion.12,13 Therefore, following our previous study on the
inhibitory effect of SDF on the activity of MMPs,18 this study
investigated the inhibitory effect of SDF on cathepsins.
According to the results of this study, the first null
hypothesis was rejected and the second null hypothesis
was accepted. The SDF solutions had high percentage of
inhibition on both cathepsin B and K. No statistically
significant difference in the percentage inhibition between
the three concentrations of SDF solutions.
In this study, a QXLTM 520/HiLyte FluorTM 488 FRET peptide
was used as the substrate for the detection of cathepsin
activities. Enzyme substrates based on FRET are sensitive tools
for determining protease activity. The fluorescence of HiLyte
FluorTM 488 is quenched by QXLTM 520 until cathepsin B or K
cleaves the peptide into two separate fragments. Upon
cleavage, the fluorescence of HiLyte FluorTM 488 is recovered,
and can be continuously monitored at Ex/Em = 488/520 nm.
Therefore, inhibited cathepsin B or K enzymatic activity will
result in a decrease of RFU. It is important to note that
proteolytic degradation of the dentinal proteins mediated by
the host cathepsins and MMPs in carious lesions is an intricateprocess. This study used recombinant cathepsins to represent
the cathepsins in dentine to act on the FRET substrate, which
is a commercial peptide. Acid and enzymatic attacks continue
over time during lesion development. In this study, the assay
system tested measured a defined end-point effect, which is
not the long lasting effect of F and Ag+. Nevertheless, the
fluorescent cathepsins assay kit was easy to use and the
cathepsins activity was able to be quantified to compare the
inhibitory effects of different experimental solutions. Another
advantage of this method is that the 96-well plate allowed
large numbers of samples to be evaluated simultaneously.18
Cysteine cathepsins were recently found to have expres-
sion in pulp tissue, and sound and carious dentine.12,13
Cathepsin B was reported to cleave the non-helical telopeptide
extensions of collagens. Moreover, cathepsin B contributes to
the potential cathepsin-MMP interplay. Pro-cathepsin B can be
activated by active MMPs, and conversely, cathepsin B has
been shown to be responsible for the activation of MMPs in
fibroblast cultures.23 Cathepsin K is a unique protease that is
both a telopeptidase and a collagenase.24 It is also the only
cysteine cathepsin capable of cleaving collagen at the triple
helical region. Cathepsin K is involved in mineralised tissue
resorption under normal and pathological conditions. The
cathepsin activity in carious dentine significantly increases
with increasing depth, indicating that odontoblast- or pulp-
derived cathepsins may be important in actively progressing
j o u r n a l o f d e n t i s t r y 4 2 ( 2 0 1 4 ) 3 2 9 – 3 3 5334carious lesions, particularly in young patients.13 These
findings suggest that cathepsins play a significant role in
dentinal caries development. The substantial inhibitory effect
of SDF on cathepsins B and K could be a reason for the success
of SDF in arresting caries in young children.3
Cathepsins are active and stable in slightly acidic pH
environments and mostly unstable at neutral pH.15 According
to the information provided by the manufacturer, the pH of
the assay buffer of the kits used in this study is approximately
4. This provides an acidic condition for the activation of the
cathepsin enzymes. To examine whether highly alkaline (high
pH) SDF solutions affect cathepsins activity, reference groups
of the corresponding SDF concentrations were buffered with
10% nitric acid to investigate whether the acidity influenced
the inhibitory effect of SDF. The results did not show any
significant difference between the original and the buffered
SDF solutions. It is noteworthy that in this experiment, each
well of the 100 ml reaction solution contained 90 ml solution
prepared from assay buffer and 10 ml experimental solution.
Therefore, the experimental solution was diluted 10 times by
the assay buffer. Furthermore, the assay itself has a buffer
system for each cathepsin to ensure that the pH stays
relatively constant during the reaction. In this study, the final
pH of the reaction solution ranged between 4.1 and 4.2.
Therefore, the difference in the alkalinity of the SDF solution
should not affect the acidic environment for cathepsin
enzymatic activity. As cathepsins are stable in acidic condi-
tions, the inhibitory effect of SDF on cathepsins should not be
due to the high pH of the SDF solutions.
In this study, the solutions with equivalent Ag+ showed a
high rate of inhibition on both cathepsin B and K. However, the
solutions with equivalent F only showed a slight degree of
inhibition. The equivalent concentration of sodium chloride,
inert as an ionisable substance, might be a possible compari-
son to discuss on the mechanism from a view point of effect of
the ion strength. Therefore, Ag+ contributed more to the
inhibitory effect of SDF than F. Ag+ nano-particles were
shown to have great inhibitory effect on cariogenic bacteria
growth, such as Streptococci mutans and Streptococci sanguis.25
Nano-particles can break through the permeability of the
outer membrane of bacteria cell and inactivate respiratory
chain dehydrogenase.26 The large ionic radius and low
oxidation state of Ag+ have great affinity with protein27 and
this may contribute to its inhibitory effect on the elastase and
cathepsin proteinases. The metal ion probably interacts with a
reactive side chain of the enzymes to inactivate their catalytic
functions. All 3 concentrations of SDF were found to have
more profound inhibitory effects on cathepsins than on
MMPs.18 In this study, the 12% SDF solution showed a strong
inhibitory effect on cathepsins. This suggests that Ag+ is a
strong inhibitor of cathepsins B and K. In oral cavity, Ag+ in
SDF can be washed away by saliva, the amount of Ag+ is
reduced in carious lesion. There are two possible mechanisms
by which the degradation of collagen is inhibited. One is
blocking the active site of the collagen against the enzymatic
attack. The second is inactivation of the enzymes-mediated
collagen degradation.28 Ag+ could form less soluble deposits
onto dentine with phosphate, chloride, oxide and proteins.
These less soluble deposits will release Ag+, to ambient fluids.
The released Ag+, probably at a minute concentration mightexert the inhibitory effect on the presence of enzymes in the
fluid. These two mechanisms will be expecting to provide long
lasting effectiveness due to the strong reaction of Ag+ to the
collagen and due to a small amount of Ag+ release.
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